About us
A Total Solution Provider in AI-Enabled Precision Biomedical and Health Innovation
Founded in 2018, Bridgent Biotechnology Inc. is well-positioned itself as an industry expert in the integration of biomedical technology with artificial intelligence (AI) and advanced data analytics. By leveraging on our extensive global network, we provide professional and customized solutions for biomedical R&D, commercialization strategies, and smart healthcare advancements.
We are dedicated to empowering Taiwanese companies to expand globally and creating market opportunities for international entry into Taiwan.

Vision
Our vision is to become a premier leader in smart healthcare and theranostics in the Asia-Pacific region, bringing innovative biomedical technologies to the global market and benefit all patients worldwide.
Mission
To enhance our AI-driven technology platform and cultivate interdisciplinary collaboration, we deliver precision medicine solutions to bioindustry and to accelerate the lab results to become market values.
Core Technologies and Products

AI-enabled Smart Healthcare Solutions
We harness cutting-edge AI technologies to integrate global resources and expertise, providing comprehensive support and insights that drive the adoption of innovative healthcare solutions.

Building the Future Healthcare
Bridgent is committed to laying the foundation for the next generation of healthcare, ensuring businesses stay competitive edge in an evolving global market.

Strategic Consulting Services
From product design to market entry, we offer tailored strategies that help businesses optimize resources and strengthen their competitive position in the global market.

Enhancing Theranostics Development Efficiency
- We leverage AI and big data to provide strategic insights that optimize drug design, development processes, and testing efficiency
- Our consulting services help create personalized treatment plans through advanced data analysis, improving decision-making and patient outcomes.
- We collaborate with leading medical institutions and enterprises worldwide to guide cutting-edge researches and help develop new approaches addressing unmet medical needs.